Clinical Trial: Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Metabolic Dysfunction-associated Steatotic Liver Disease
Study Type: OBSERVATIONAL
Official Title: Epidemiologic Liver Outcomes Retrospective Study to Confirm The Prognostic Value of the FibroNest Digital Pathology Fibrosis Biomarker (Ph-FCS) in Patients With MASLD (DPAILO-2)
Brief Summary:
The aim of this multi-center, retrospective epidemiologic study is to confirm the prognostic performance of the Digital Pathology (DP) FibroNest Phenotypic Fibrosis Composite Score (Ph-FCS), derived from standard digital pathology liver biopsy images, in predicting clinical hepatic decompensation events in patients with metabolic dysfunction-associated steatohepatitis (MASH).
Read more